Search
for
Sort by
Research 661–690 of 667
- Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients
- Evaluation of the Hemogram of Breast Cancer Patients Treated by Therapeutic Protocol Based on Immunohistochemical Analysis: A Retrospective Study
- Follicular unit extraction method of hair transplantation: Technique, advantages and limitations
- Drug Treatment of Acute Leukaemia Current Status
- Androgenetic alopecia – Update 2022
- One year cross-sectional study of association between androgenetic alopecia and benign prostatic hyperplasia in a tertiary care hospital
- Tamoxifen-induced androgenetic alopecia in a dialysis patient with sclerosing encapsulating peritonitis (SEP)
- Venous and pulmonary thromboembolism and combined hormonal contraceptives. Systematic review and meta-analysis
- Venous thromboembolism and women's health
- Use of combined oral contraceptives and risk of venous thromboembolism in young women: a nested case–control analysis using German claims data
- 52309 Association of venous thromboembolism in patients with alopecia areata
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- PD49-03 IS TADALAFIL ASSOCIATED WITH DECREASED RISK OF MAJOR ADVERSE CARDIAC EVENTS OR VENOUS THROMBOEMBOLISM IN MEN WITH LOWER URINARY TRACT SYMPTOMS?
- The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).
- Combined hormonal contraception and venous thromboembolism
- Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20–59 Years in the United Kingdom’s CPRD 1995–2015
- Alopecia areata does not increase the risk of venous thromboembolism: an All of Us case-control study
- C85. Right heart failure due to chronic thromboembolic pulmonary hypertension in systemic lupus erythematosus patient: a case report
- C85. Right heart failure due to chronic thromboembolic pulmonary hypertension in systemic lupus erythematosus patient: a case report
- Incidence Rates of Infections, Malignancies, Thromboembolism, and Cardiovascular Events in an Alopecia Areata Cohort from a US Claims Database
- Endocrinology of Transgender Medicine
- Endocrine intervention for transsexuals
- Contraception and the dermatologist
- Evaluation of Risk-Minimization Activities for Cyproterone Acetate 2 mg/Ethinylestradiol 35 µg: A Cross-Sectional Physician Survey
- Women’s Health Considerations for Lipid Management
- Rheumatologic Manifestations of Pregnancy
- A protocol for assessment of interventions using a computational phenotype for Long COVID
- HORMONAL IMPLANTS, BEAUTY CHIP; BENEFITS AND HARMFUL
- Vitamins
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata